Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02912195 · ClinicalTrials.gov registry record · Phase 4

Intravenous Lidocaine Versus Morphine for Severe Pain in the ED

A Phase 4 study of Pain, sponsored by Alameda Health System.

Completed
Registry status
Phase 4
Development phase
32
Enrollment target
1
Study location

NCT02912195 is a Phase 4 study of Pain that has completed, run by Alameda Health System. The registered enrollment target is 32 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02912195, a Phase 4 study of Pain, has completed, sponsored by Alameda Health System.

COMPLETED
Registry status
Phase 4
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department. Study design: Open-label, randomized controlled pilot study.

Conditions Studied

Pain

Interventions

  • DRUG Intravenous lidocaine
  • DRUG Intravenous morphine

Study Locations (1)

California

  • Alameda Health System, Highland Hospital - Oakland

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-03
Est. Completion 2016-09
Phase Phase 4

Sponsor

Alameda Health System

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02912195

The ClinicalTrials.gov registry entry for NCT02912195 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower). The listed sponsor is Alameda Health System, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Intravenous lidocaine is the first listed.

NCT02912195 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02912195 about?

NCT02912195 is a clinical study titled "Intravenous Lidocaine Versus Morphine for Severe Pain in the ED". Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider chosen dose of IV morphine for the treatment of severe pain in the emergency department. Study design: Open-label, randomized controlled pilot study.

What is the current status of trial NCT02912195?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2016-03. Estimated completion is 2016-09.

What conditions does trial NCT02912195 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02912195?

The interventions under investigation include: Intravenous lidocaine (DRUG), Intravenous morphine (DRUG).

Who is sponsoring clinical trial NCT02912195?

This trial is sponsored by Alameda Health System, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02912195 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.